Provista Life Sciences LLC' Chief Medical Officer to Speak on Early Cancer Detection at National Institutes of Health (NIH) Conference

PHOENIX--(BUSINESS WIRE)--Provista Life Sciences LLC (www.ProvistaLS.com), a medical diagnostic development and commercialization company, announced today Louis Kirby, MD, Chief Medical Officer, was selected by the National Institutes of Health to present information on the clinical applications of biomarkers in the early detection of cancer at the 5th annual meeting of the National Cancer Institute’s Early Detection Research Network.